What is CONMED's derivatives, gross, liabilities?

CONMED (CNMD) reported derivatives, gross, liabilities of $3.83M in Q1 2026.

How has CONMED's derivatives, gross, liabilities changed year-over-year?

CONMED's derivatives, gross, liabilities increased by 8.3% year-over-year, from $3.53M to $3.83M.

What is the long-term trend for CONMED's derivatives, gross, liabilities?

Over 5 years (2020 to 2025), CONMED's derivatives, gross, liabilities has grown at a -9.0% compound annual growth rate (CAGR), from $9.51M to $5.94M.

CONMED CNMD Derivatives, gross, liabilities

Derivatives, gross, liabilities at other companies

Boston ScientificBSX

——

MedtronicMDT

——

Other financials

Income statement

See full

Revenue$317.0M-1.3%

Gross profit$183.4M+3.2%

Operating income$25.4M+59.3%

Net income$13.8M+129%

EPS (diluted)$0.45+137%

Balance sheet

See full

Cash & equivalents$35.0M-1.3%

Total debt$862.6M-3.6%

Total equity$1.0B+4.1%

Total assets$2.3B+0.8%

Cash flow

See full

Operating cash flow$13.5M-67.6%

CapEx$2.9M-23.5%

Free cash flow$10.6M-72.0%

Valuation

See full

Market cap$1.04B-35.6%

Enterprise value$1.87B-24.5%

P/E19×+5.4×

P/S0.8×-0.5×

Profitability

See full

Gross margin55.2%-1.0pp

Operating margin8.2%-5.6pp

Net margin4%-5.0pp

FCF margin9%-3.5pp

Returns & leverage

See full

Return on equity5.5%-7.5pp

Debt / equity0.8×-0.1×

Current ratio2.3×0.0×

Where this comes from

Reported directly by CONMED in its filing.

Tagged under the XBRL concept us-gaap:DerivativeFairValueOfDerivativeLiability.

The official record: CONMED’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about CONMED's derivatives, gross, liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is CONMED's derivatives, gross, liabilities?: CONMED (CNMD) reported derivatives, gross, liabilities of $3.83M in Q1 2026.
How has CONMED's derivatives, gross, liabilities changed year-over-year?: CONMED's derivatives, gross, liabilities increased by 8.3% year-over-year, from $3.53M to $3.83M.
What is the long-term trend for CONMED's derivatives, gross, liabilities?: Over 5 years (2020 to 2025), CONMED's derivatives, gross, liabilities has grown at a -9.0% compound annual growth rate (CAGR), from $9.51M to $5.94M.